LISINOPRIL AND HYDROCHLOROTHIAZIDE

Generic: LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS

Exelan PharmaceuticalsManufacturer
ORALRoute
LISINOPRILActive Substance
2017-05-23Original Approval

LISINOPRIL AND HYDROCHLOROTHIAZIDE is FDA application ANDA204058, sponsored by INVAGEN PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
NAUSEA
547 reports
2
FATIGUE
538 reports
3
DIARRHOEA
487 reports
4
DRUG INEFFECTIVE
480 reports
5
DIZZINESS
393 reports
6
PAIN
384 reports
7
HEADACHE
336 reports
8
DYSPNOEA
319 reports
9
COUGH
291 reports
10
VOMITING
282 reports